Louis Kayitalire - Jul 2, 2021 Form 4 Insider Report for F-star Therapeutics, Inc. (FSTX)

Role
Chief Medical Officer
Signature
/s/ Darlene Deptula-Hicks, Attorney-in-fact
Stock symbol
FSTX
Transactions as of
Jul 2, 2021
Transactions value $
-$8,885
Form type
4
Date filed
7/7/2021, 09:13 PM
Previous filing
Aug 24, 2021
Next filing
Oct 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FSTX Common Stock Sale -$8.89K -1.05K -1.9% $8.43 54.4K Jul 2, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to the 10b5-1 Plan entered into by the Reporting Person.
F2 Includes 48,828 restricted stock units.